May 18, 2022
BREAKING NEWS
ASH 2021: Dr. Jennifer Woyach with an Update on Ibrutinib vs. Chemoimmunotherapy as a Frontline Treatment for Chronic Lymphocytic Leukemia
An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity
Application of National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for CLL/SLL from the informCLL Real-World Registry
ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

Support Groups  |  Researchers

Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Newsletter Sign Up
Donate Now

Support Groups  |  Researchers

CLL Society Webinar Archive: Global Virtual Patient & Caregiver Educational Forum – Session 2

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

 

Recorded Saturday, October 10, 2020

Session 2: Being Your Own Advocate

Continue to Session 3: Frontline Therapy Options, Measuring Response, Including MRD

CLL Society Resources

Download Slides
Audience Questions
Agenda
About CLL Society
Sign up for CLL Society's This Week emails
Test Before Treat™
Expert Access Program
Normal Lab Values
Keeping Track of Lab Results
CLL Society Patient and Caregiver Support Groups
COVID-19 Updates
Please Consider Donating to CLL Society

Ask the Experts

Support Groups

Upcoming Events

Expert Access™

Education On-Demand

RECENT NEWS

CLL SOCIETY FAST FIND

One click to our most popular content.

xFINAL Newly Diagnosed 150x107
xFINAL Treatment And Research 107
xFINAL Normal Lab Values 32122
xFINAL Free CLL Expwert Opinion 107
quicklinks
QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF OFFICIAL
CLL DOCTORS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS